McMaster researchers test fecal transplantation to treat ulcerative colitis

Two new studies led by researchers from the Farncombe Family Digestive Health Research Institute at McMaster University show that transplantation of fecal matter may be a useful tool in the fight against ulcerative colitis (UC). Ulcerative colitis is a chronic, debilitating inflammatory bowel condition characterized by symptoms including bloody stools, diarrhea, abdominal...

Read More

FDA strengthens heart safety warnings on painkillers

People should think carefully about taking these drugs, both over-the-counter versions and prescription pills, the FDA says. It’s asking manufacturers to change the labels.”They used to say they might cause risk of heart attack or stroke. Now we are saying they do cause increased risk of heart attack and stroke,The warning covers drugs called nonsteroidal anti-inflammatory...

Read More

FIRST EVER INHALABLE EBOLA VACCINE IS SUCCESSFUL IN SIMIAN TRIALS.

July 14, 2015 A collaborative team from The University of Texas and the National Institutes of Health have developed an inhalable vaccine that successfully protects primates against Ebola in simian trials. The team state that a needle-free, inhalable vaccine against Ebola presents certain advantages as it has been shown that this disease lines respiratory tract in infection,...

Read More

FIRST PATIENT IN THE WORLD BRIDGED TO A SUCCESSFUL HEART TRANSPLANT VIA A TOTAL ARTIFICIAL HEART.

A petite 44-year-old woman has become the first patient in the world to be bridged to a successful heart transplant, that is, to go from needing a transplant to receiving one, with an experimental Total Artificial Heart designed for smaller patients.  The UCLA patient received a successful heart transplant at Ronald Reagan UCLA Medical Center, thanks to the smaller...

Read More

THE TOP TEN HEALTH INNOVATIONS OF 2014.

A great year for health innovations with exciting discoveries, verification, validations and breakthroughs.  The big disease areas are still cancer, heart disease, diabetes and Alzheimer’s, however, it’s the methodology of detection, imaging, and the descriptive diagnostics that have been innovated this year.  In some cases these disciplines and techniques bleed...

Read More

New Heart Drug From Novartis Gets FDA Approval — Now The Major Pricing Battle Begins

It used to be that the major hurdle in getting a new drug approved was successfully completing phase 3 trials – the long-term studies needed to prove to regulators that your drug was both effective and safe. These trials can take years to run and cost hundreds of millions of dollars. Yet, despite doing successful studies for many years in preparation for phase 3, these...

Read More